MCM
AVXL icon

Massar Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Massar Capital Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33K Buy
+12,729
New +$37.7K ﹤0.01% 262

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Massar Capital Management's AVXL Position: Q2 2026 in Review

Massar Capital Management opened a new position in Anavex Life Sciences (AVXL) in Q2 2026: 12,729 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #262 among its holdings.

179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Massar Capital Management held 12,729 shares of Anavex Life Sciences worth $33K as of Q2 2026.
  • Anavex Life Sciences was a new Massar Capital Management position in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of Massar Capital Management's portfolio in Q2 2026, its #262 holding.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Massar Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.